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radiation delivery have increased the importance of bladder pre-
serving strategies using radiotherapy, while also improving
patient’s quality of life. However, the outcome of radiotherapy
depends on the radiosensitivity of both the patient and his/her
tumour. Recent developments in radiobiology have highlighted
the importance of the assessment of radiation-induced DNA
double-strand breaks (DSB) repair kinetics in predicting radio-
sensitivity of both normal and cancerous tissues. Indeed, after
irradiation, several proteins (ATM, gH2AX, etc.) involved in the
signalling and repair of DNA DSB relocalize as nuclear foci. The
purpose of this study is to characterise the radiosensitivity of
bladder cell lines, based on their capacity to repair radio-induced
DNA damage.
Material and methods Four human bladder cell lines were used
in this study: T24, UM-UC3, RT4 and SVHUC. Clonogenic
assay was performed to study cell survival after irradiation:
cells were irradiated with doses ranging from 0 to 10 Gy and
their capacity to form colonies was assessed. Immunofluores-
cent analysis using anti-pATM and anti-gH2AX antibodies was
then performed to assess DNA DSB signalling and repair
kinetics after a 2Gy irradiation. Finally, we performed the
three-dimensional (3D) sphere formation assay to assess the
effect of irradiation on cancer/stem progenitor cells. Irradiated
cells with doses ranging from 0 to 10 Gy were embedded in
Matrigel and their capacity to form spheres was assessed.
Results and discussions RT4 was found to have the highest
survival rate after irradiation, followed by T24, UM-UC3 and
SVHUC according to the clonogenic assay results. Immuno-
fluorescence results were consistent with cell survival as RT4
showed the fastest DSB recognition and repair kinetics while
SVHUC had a much slower rate. Furthermore, the capacity of
cells to recognise radio-induced DNA damage was found to
have the best correlation with their survival. Lastly, the sphere
formation ability of the different cell lines showed a differen-
tial response to increasing irradiation doses.
Conclusion We were able to radiobiologically characterise 4
human bladder cell lines by assessing their survival and
capacity to repair radio-induced DNA damage. Moreover, we
showed the differential effects of radiation on cancer stem/
progenitor cells. The results highlighted the importance of
DNA DSB signalling through the ATM protein and its role in
cell survival after irradiation.
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Introduction MicroRNAs (miRNAs) are evolutionarily con-
served, endogenous, small noncoding RNAs that regulate the
stability and translation of target mRNA by primarily binding to
the 3¢ -UTR18. MiRNAs have been reported to be involved in
DNA damage response induced by ionising radiation (IR). c-Myc
is reduced when cells treated with IR or other DNA damaging
agents. However, it is unknown whether miRNAs participate in
c-Myc downregulation in response to IR. MicroRNA-449a is
deregulated in various types of cancers, including prostate
cancer.
Material and methods The human prostate cancer lines,
LNCaP, PC-3 and DU-145 cells in exponential growth were
irradiated by x-rays at room temperature. Overexpressing
miR-499a and miR-con was generated by plasmid transduction
using GV214. MiR-449a antagomir (anti-miR-449a) and non-
targeting sequence were synthesised. Transfection was per-
formed with Trans IT 2020 Transfection Reagent. The cell
viability assay was carried out basis on thiazolyl blue tetrazo-
lium blue (MTT). Cell proliferation was analysed using Cell
Counting Kit-8(CCK-8). Cell cycle analysis was acquired using
FACS Calibur flow cytometer. MiRNAs and mRNA expression
were determined using quantitative RT-PCR analysis. Protein
expression were analysed by western blotting.
Results and discussions In the present study, we found that
miR-449a was upregulated and c-Myc was downregulated in
response to IR in LNCaP cells. Overexpression of miR-449a
or knockdown of c-Myc promoted the sensitivity of LNCaP
cells to IR. By establishing c-Myc as a direct target of miR-
449a, we revealed that miR-449a enhanced radiosensitivity by
repressing c-Myc expression in LNCaP cells. Moreover, we
showed that miR-449a enhanced radiation-induced G2/M
phase arrest by directly downregulating c-Myc, which con-
trolled the Cdc2/CyclinB1 cell cycle signal by modulating
Cdc25A. In summary, our study reported here demonstrated
that miR-449a enhanced the sensitivity of LNCaP cells to IR
by directly targeting c-Myc, which controlled the Cdc2/
cyclinB1 cell cycle signal by modulating Cdc25A/Rb/E2F path-
way. Furthermore, we found that both miR-449a and c-Myc
responded to irradiation and either overexpression of miR-
449a or knockdown of c-Myc sensitised LNCaP cells to
irradiation.
Conclusion These findings highlighted an unrecognised mecha-
nism of miR-449a-mediated c-Myc regulation in response to
IR, which provides a support for the combination of ionising
radiation with miRNAs regulation as a therapeutic strategy for
patients with prostate cancer.
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Introduction A high cellular radiosensitivity is connected with a
risk for development of severe side effects after radiotherapy. In
this study we have attempted to find a correlation between the
initial radiosensitivity of in vitro irradiated peripheral blood
mononuclear cells (PBMC) of prostate cancer patients and the
adverse side effects of radiotherapy.
Material and methods PBMCs isolated from 7 prostate cancer
patients, before the onset of radiotherapy and 3 healthy men
were exposed in vitro to 2 Gy of x-ray radiation (Varian, 6
MeV). Following irradiation cell death was measured using the
Annexin V/PI assay. DNA repair kinetics (0 and 24 hour after
irradiation) was performed using the comet assay, and the
results were expressed as% of tail DNA. Acute toxicity were
graded according to the EORTC radiation morbidity scoring
scale.
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Results and discussions Our data show that the in vitro irradi-
ation of PBMCs in prostate cancer patients initially caused a
significantly higher DNA damage than in the control group of
healthy donors. After a repair time of 24 hour, samples from
all healthy donors showed no residual DNA damage (average
2.6%) in PBMCs. If all patients are observed for 0 hour and
24 hour after in vitro PBMCs irradiation then there is a sig-
nificant reduction in the degree of DNA damage, from 35.5
to 30.4 tail% DNA. What is also important is that 4 patients
had a very low level of DNA damage, which can be consid-
ered as normal cellular reaction to irradiation, while 3 patients
had a very high level of damage. Also, in 5 out of 7 exam-
ined prostate cancer patients, there was an increase in the per-
centage of PBMCs in the early and late stages of apoptosis
24 hour after in vitro irradiation of their PBMCs. Most
patients had mild side reactions to radiotherapy and were
graded as grade 1 (per EORTC scale). Only in 1 of 7 patients
observed side effects are classified as grade 2 and this is in
correlation with a very high level of DNA damage (82.25%
initial, versus 64.77% 24 hour after in vitro irradiation).
Conclusion Our study was insufficient to reveal the relation-
ship between the risk of developing side effects to radiother-
apy and the sensitivity of PBMCs irradiated in vitro, measured
by comet assay. A larger number of patients and further stud-
ies are necessary to confirm the potential application of the
comet assay.
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Introduction Pancreatic ductal adenocarcinoma (PDAC) is one of
the five most lethal malignancies in the world and has a 5 year
relative overall survival rate of less than 5%. Thus, there is a
great need for functional targeting strategies. As cell-matrix
adhesion is essential for the survival, invasion and therapy resist-
ance, we sought to identify the function of 117 focal adhesion
proteins (FAP) in PDAC cell radiochemoresistance. Intriguingly,
b8 integrin turned out to be one of the most potential novel tar-
gets in PDAC.
Material and methods We performed a 3D endoribonuclease-
prepared siRNA (esiRNA)-based high throughput screening
(3DHTesiS) in PDAC cell cultures (established and patient-
derived (PDC)) grown in laminin-rich extracellular matrix
(IrECM). In addition to characterising b8 integrin expression,
distribution and co-localization with other cellular organelles
such as golgi apparatus, clonogenic survival assays were per-
formed upon esiRNA-mediated knockdown, X-ray irradiation
(6 Gy single dose) and gemcitabine. Fiji software was used to
determine Peason’s correlation coefficient, vesicle distribution
and expression patterns upon irradiation or gemcitabine. An
inhibitor screen was conducted to identify pathway involved
in changes of b8 integrin localization upon treatment.
Results and discussions We identified a series of novel targets
including b8 integrin. Without cytotoxicity, b8 integrin deple-
tion elicited radiochemosensitization in PDAC, PDCs cell lines
and reduced sphere formation and 3D invasion into collagen-
I. Intriguingly, we found b8 integrin located in perinuclear
area where it colocalized with the cis-Golgi matrix protein
GM130. Upon irradiation and gemcitabine, b8 integrin disso-
ciated from the perinuclear region and spread throughput the
cytosol without enhanced localization to exosomes; a process
abrogated by antimycin A or oligomycin pre-treatment.
Conclusion Our findings, generated in 3D lrECM PDAC cell
ccultures, suggest b8 integrin as a novel determinant of PDAC
radiochemoresistance. Moreover, b8 integrin may, although
not found in the cell membrane to facilitate cell adhesion, a
critical role in intracellular vesicle trafficking under stress con-
ditions. Ongoing work will unravel the underlying mechanisms
how b8 integrin is controlling cytoplasmic and nuclear survival
pathways.
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Introduction Hypoxia-mediated resistance of solid tumours to
ionising radiation is a major obstacle to successful radiotherapy.
We showed previously that chronic cycling hypoxia drives the
evolution of anoxia/reoxygenation-tolerant (ART) cancer cells
with increased resistance to ionising radiation. Radiation resist-
ance of ART cancer cells was associated with complex metabolic
reprogramming, Matschke et al., Antioxid Redox Signal
201625:89–107; Matschke et al., Radiat Oncol 201611(1:75).
Aim of the present study was to gain a more comprehensive
understanding of the metabolic adaptation of cancer cells and to
systematically explore opportunities for targeted pharmacologic
intervention based on their suspected specific metabolic needs
upon irradiation.
Material and methods We compared gene expression profiles
of ART and control cancer cells by microarray analysis and
validated genes of interest by qRT-PCR. We used LC-MS
high-throughput metabolomics, metabolic flux analyses,
nutrient deprivation and drugs interfering with metabolism to
characterise the cellular metabolic state without/with
irradiation.
Results and discussions Our microarray data indicated changes
in major metabolic pathways after chronic cycling hypoxia
selection. Furthermore, tolerance to severe hypoxia was associ-
ated with the formation of enlarged mitochondria in ART
NCI-H460 cells. The analysis of metabolic alterations in irra-
diated cancer cells by LC-MS high-throughput metabolome
analysis demonstrated a high and time-dependent need of irra-
diated cancer cells in central metabolism. Targeting of induced
metabolic alterations disturbed redox homeostasis, altered
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